ENTRY       D10689                      Drug
NAME        Amifampridine phosphate (JAN/USAN);
            Firdapse (TN)
PRODUCT     FIRDAPSE (Catalyst Pharmaceuticals)
FORMULA     C5H7N3. H3PO4
EXACT_MASS  207.0409
MOL_WEIGHT  207.1244
REMARK      ATC code: N07XX05
            Chemical structure group: DG02003
            Product (DG02003): D10689<US>
EFFICACY    Autoimmune disease treatment, Potassium channel blocker
  DISEASE   Lambert-Eaton myasthenic syndrome [DS:H01596]
COMMENT     Treatment of Lambert-Eaton myasthenic syndrome (LEMS)
TARGET      KCNA [HSA:3736 3737 3738 3739 3741 3742 3743 3744] [KO:K04874 K04875 K04876 K04877 K04878 K04879 K04880 K04881]
            KCNB [HSA:3745 9312] [KO:K04885 K04886]
            KCNC [HSA:3746 3747 3748 3749] [KO:K04887 K04888 K04889 K04890]
            KCND [HSA:3750 3751 3752] [KO:K04891 K04892 K04893]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07X OTHER NERVOUS SYSTEM DRUGS
                N07XX Other nervous system drugs
                 N07XX05 Amifampridine
                  D10689  Amifampridine phosphate (JAN/USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Central Nervous System Agents
              Central Nervous System, Other
               Amifampridine
                D10689  Amifampridine phosphate (JAN/USAN)
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Potassium channels
                KCNA
                 D10689  Amifampridine phosphate (JAN/USAN) &lt;US&gt;
                KCNB
                 D10689  Amifampridine phosphate (JAN/USAN) &lt;US&gt;
                KCNC
                 D10689  Amifampridine phosphate (JAN/USAN) &lt;US&gt;
                KCND
                 D10689  Amifampridine phosphate (JAN/USAN) &lt;US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10689
DBLINKS     CAS: 446254-47-3
            PubChem: 254741650
ATOM        13
            1   C8y C    20.3700  -16.7300
            2   C8x C    20.3700  -18.1300
            3   N5x N    21.5600  -18.8300
            4   C8x C    22.8200  -18.1300
            5   C8x C    22.8200  -16.7300
            6   C8y C    21.5600  -16.0300
            7   N1a N    21.5600  -14.6300
            8   N1a N    19.1800  -16.0300
            9   P1b P    26.4600  -17.6400
            10  O1c O    26.4600  -16.2400
            11  O1c O    27.8600  -17.6400
            12  O1c O    25.0600  -17.6400
            13  O1c O    26.4600  -19.0400
BOND        12
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     6   7 1
            8     1   8 1
            9     9  10 2
            10    9  11 1
            11    9  12 1
            12    9  13 1
///
